Whole Slide Imaging Market Report by Technology, Application, End User, and Region 2024-2032
세계의 홀 슬라이드 이미징 시장 규모는 2023년에 7억 6,970만 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 19억 290만 달러에 달하며,2024-2032년 동안에 10.4%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다.
홀 슬라이드 이미징(WSI)은 조직 절편의 고해상도 정밀 디지털 이미지를 생성하는 데 사용되는 슬라이드 글래스 스캔으로, 초점 장비, 카메라, 조명 시스템, 스캐너, 뷰어, 이미지 관리 시스템 및 현미경 광학 부품으로 구성됩니다. WSI는 전용 스캐너를 사용하여 슬라이드 글라스를 디지털화하여 대형 디지털 이미지를 생성합니다. 면역조직화학, 원격 병리학, 혈액병리학, 세포병리학에서 널리 사용되는 WSI는 정확도 향상, 분석 속도 향상, 생산성 향상, 오류 감소, 신뢰할 수 있고 편리한 결과 제공에 도움이 되고 있습니다. 그 결과, 학술 및 연구기관, 생명공학 및 제약회사, 병원 및 클리닉 등에서 널리 사용되고 있습니다.
홀슬라이드 이미징 시장 동향 :
헬스케어 산업의 괄목할 만한 성장과 전 세계에서 환자 안전에 대한 관심이 높아지면서 시장 전망을 밝게 하는 주요 요인으로 작용하고 있습니다. 또한 생활습관의 변화, 유전자 변이, 흡연 및 음주 습관 증가로 인한 암 유병률 증가는 시장 성장을 가속하고 있습니다. 이에 따라 WSI는 피부암, 폐암, 유방암 의심 진단 절차에 널리 사용되고 있으며, 이는 시장 성장에 더욱 탄력을 받고 있습니다. 또한 인공지능(AI)과 머신러닝(ML)을 통합하여 다양한 질병과 진단을 지원하고 정밀의료를 제공하는 등 다양한 기술 발전이 시장 성장에 상당한 탄력을 받고 있습니다. 이에 따라 조직 샘플의 단백질 발현을 관찰하고 세포내 항원을 검출하는 면역조직화학(IHC)에서 홀슬라이드 이미징이 널리 채택되고 있는 것도 시장 성장에 긍정적인 영향을 미치고 있습니다. 신약 개발에 대한 제품 수요 증가와 광범위한 연구개발(R&D) 활동 등 다른 요인들도 시장 성장을 가속할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 서론
제5장 세계의 홀 슬라이드 이미징 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 기술별
제7장 시장 내역 : 용도별
- 면역조직화학
- 원격병리진단
- 세포 병리학
- 혈액 병리학
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁의 정도
- 신규 진출업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업의 개요
- 3DHISTECH Ltd.
- Beckman Coulter Inc.(Danaher Corporation)
- F. Hoffmann-La Roche AG
- General Electric Company
- Hamamatsu Photonics KK
- Huron Technologies Internationa
- Inspirata Inc.
- Koninklijke Philips N.V.
- Mikroscan Technologies Inc.
- Olympus Corporation
- Perkinelmer Inc.
- Visiopharm A/S
KSA
The global whole slide imaging market size reached US$ 769.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,902.9 Million by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2024-2032.
Whole slide imaging (WSI) is scanning glass slides used to produce high-resolution and precise digital images of tissue sections. It comprises a focusing unit, camera, illumination systems, scanners, viewers, image management system, and microscopic optical components. WSI utilizes a specialized scanner to digitize glass slides and generate large digital images that are analyzed, stored, and shared through the virtual slide viewer. It is widely used in immunohistochemistry, telepathology, hematopathology, and cytopathology. WSI assists in improving accuracy, speed of analysis, increasing productivity, reducing errors, and providing reliable and convenient results. As a result, it is widely used across academic and research institutes, biotechnology and pharmaceutical companies, and hospitals and clinics.
Whole Slide Imaging Market Trends:
The significant growth in the healthcare industry and the rising focus on patient safety across the globe are the prime factors creating a positive outlook for the market. Additionally, the rising prevalence of cancer due to the changing lifestyles, genetic mutation, and increasing smoking and alcohol habits is favoring the market growth. In line with this, WSI is extensively used in diagnostic procedures for suspected skin, lungs, and breast cancer, which is further providing an impetus to the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) to assist in various diseases and diagnoses and provide precision medicine delivery, are providing a considerable boost to the market growth. In line with this, the widespread adoption of whole slide imaging in immunohistochemistry (IHC) to observe protein expression in tissue samples and detect antigens in the cells is positively impacting the market growth. Other factors, such as the increasing product demand in drug discovery and extensive research and development (R&D) activities, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global whole slide imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology, application and end user.
Breakup by Technology:
Scanners
IT Infrastructure
Viewer
Image Management System
Breakup by Application:
Immunohistochemistry
Telepathology
Cytopathology
Hematopathology
Breakup by End User:
Academic Institute
Research
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3DHISTECH Ltd., Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, General Electric Company, Hamamatsu Photonics KK, Huron Technologies Internationa, Inspirata Inc., Koninklijke Philips N.V., Mikroscan Technologies Inc., Olympus Corporation, Perkinelmer Inc. and Visiopharm A/S.
Key Questions Answered in This Report:
- How has the global whole slide imaging market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global whole slide imaging market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global whole slide imaging market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Whole Slide Imaging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Scanners
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 IT Infrastructure
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Viewer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Image Management System
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Immunohistochemistry
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Telepathology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cytopathology
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Hematopathology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Academic Institute
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Research
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3DHISTECH Ltd.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 F. Hoffmann-La Roche AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 General Electric Company
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Hamamatsu Photonics KK
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Huron Technologies Internationa
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Inspirata Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Koninklijke Philips N.V.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Mikroscan Technologies Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Olympus Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Perkinelmer Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Visiopharm A/S
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
